Mesoblast (MESO) Interest Coverage Ratio Growth (3y) (2018 - 2023)
Mesoblast (MESO) Interest Coverage Ratio Growth (3y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 41.55% |
| Mar 31, 2023 | 62.54% |
| Dec 31, 2022 | 41.41% |
| Sep 30, 2022 | -36.37% |
| Jun 30, 2022 | -91.72% |
| Mar 31, 2022 | 56.06% |
| Dec 31, 2021 | -21.46% |
| Sep 30, 2021 | -36.09% |
| Jun 30, 2021 | 6.75% |
| Mar 31, 2021 | -28.00% |
| Mar 31, 2020 | -32.44% |
| Dec 31, 2019 | 25.18% |
| Sep 30, 2019 | 58.95% |
| Jun 30, 2019 | 38.08% |
| Mar 31, 2019 | -41.04% |
| Dec 31, 2018 | 0.08% |
| Sep 30, 2018 | 10.26% |
| Jun 30, 2018 | -4.17% |
| Mar 31, 2018 | 74.32% |